“降本”失灵，国药现代陷营利双降困局

Core Insights - The company reported a significant decline in both revenue and net profit for 2025, with total revenue at 9.363 billion yuan, down 14.4% year-on-year, and net profit at 944 million yuan, down 12.85% [1][4][6] - This marks the fourth consecutive year of revenue decline for the company, with previous years also showing negative growth in revenue due to pressures in both raw material and formulation businesses [4][9] - Despite the revenue decline, net profit had previously reached historical highs due to aggressive cost-cutting measures, particularly in sales expenses, which were reduced from 34.85 billion yuan in 2021 to 11.52 billion yuan in 2024 [5][6] Financial Performance - The company's operating profit for 2025 was 1.314 billion yuan, a decrease of 25% compared to the previous year [2] - The total profit for the period was 1.328 billion yuan, down 20.61% year-on-year [2] - The basic earnings per share decreased by 12.86% to 0.7041 yuan [2] Business Challenges - The decline in revenue and profit is attributed to a dual impact on core business segments, with both raw materials and formulations facing price pressures and reduced demand [6][8] - The overall gross margin decreased by 6.91 percentage points, despite a reduction in expense ratios [6] - The company is attempting to address these challenges through asset divestitures and restructuring, including the sale of a 51% stake in a subsidiary at a significant loss [8][9] Management Changes - The company has undergone significant management turnover in recent years, with multiple high-level resignations and appointments, indicating potential internal restructuring efforts [7][10] - The management changes are seen as part of a broader strategy to address ongoing performance issues and improve operational efficiency [7][10] Industry Context - The challenges faced by the company are reflective of broader issues within the "Guoyao" system, where multiple listed companies are experiencing performance pressures and are engaging in asset restructuring [9][10] - The industry is shifting from a focus on scale to efficiency, as companies seek to optimize resources and improve profitability amid competitive pressures [9][10]